October 17, 2019
Alexion has struck a deal to buy Achillion for $930M. The takeover will give Alexion two clinical-phase medicines in development in complement alternative pathway-mediated rare diseases. […]
October 18, 2019
AbbVie’s Humira is topping industry sales, but by 2025, the drug will fall to the No. 6 spot in best-selling meds, according to a new forecast […]
October 18, 2019
Bayer has signed onto new collaborations with 11 digital health startups, spanning areas such as oncology, ophthalmology, pulmonology, radiology, digital therapeutics, and cardiovascular health. Formerly known […]
October 18, 2019
Meditech is teaming up with Google to put patient data onto the cloud. It is one of the first vendors to offer an enterprise health record […]
October 18, 2019
Alexion has struck a deal to buy Achillion for $930M. The takeover will give Alexion two clinical-phase medicines in development in complement alternative pathway-mediated rare diseases. […]
October 20, 2019
By Robert Ruth, Vice President & Managing Director, Ashton Tweed See this article on LinkedIn. With over 25 years of experience driving recruitment strategies and providing support […]
November 1, 2019
Amgen is stopping its neuroscience research – with the exception of programs centered on neuro-inflammation – as the company concluded that their efforts were unlikely to […]
November 8, 2019
Looking to the world’s second largest healthcare market, AstraZeneca is helping set up a life sciences venture fund to groom Chinese startups that could turn into […]
November 13, 2019
As female professionals fight to slowly increase their representation in the C-suite, the life sciences industry provides no shortage of excellent female leaders. See who made […]